How to Get Alprostadil (Caverject/MUSE) in Texas

Who Prescribes Alprostadil in Texas

Any physician (MD or DO) licensed by the Texas Medical Board can prescribe alprostadil. Nurse practitioners and physician assistants may also prescribe it, though Texas law requires NPs and PAs to maintain a prescriptive authority agreement with a supervising physician under the Texas Occupations Code Chapter 157. In practice, urologists and men's health specialists write most alprostadil prescriptions, but primary care physicians and endocrinologists prescribe it too.

The American Urological Association (AUA) guidelines on erectile dysfunction list alprostadil as a second-line therapy for men who do not respond to or cannot tolerate oral PDE5 inhibitors such as sildenafil or tadalafil [1]. The 1996 Linet and Ogrinc trial in the New England Journal of Medicine (N=296) demonstrated that intracavernosal alprostadil produced erections sufficient for intercourse in 87% of injections, compared with 13% for placebo [2]. That data remains foundational to prescribing decisions today.

Texas has no state-specific restriction limiting alprostadil prescribing to specialists. A family medicine physician in El Paso has the same authority as a urologist in Houston, provided the prescriber documents a clinical indication and conducts appropriate evaluation.

Telehealth Prescribing of Alprostadil in Texas

Texas allows telehealth prescribing of alprostadil. The state expanded telehealth access through SB 1107 (2019), and subsequent regulatory updates have maintained broad prescriptive authority for synchronous telemedicine encounters. A prescriber must establish a valid patient-provider relationship via a real-time audiovisual visit before writing the prescription.

Several national men's health telehealth platforms operate in Texas and offer alprostadil consultations. The typical workflow involves completing an intake questionnaire, uploading recent lab results, and joining a video visit with a licensed clinician. If appropriate, the clinician writes the prescription and sends it to a retail or compounding pharmacy.

One limitation: alprostadil requires dose titration. The FDA-approved labeling for Caverject recommends that the initial dose be administered in a physician's office so that the clinician can monitor for prolonged erection (priapism) and adjust the dose [3]. Some telehealth providers partner with local clinics in Texas cities (Dallas, Houston, San Antonio, Austin) to support in-office titration before the patient transitions to home self-injection. Others require patients to arrange titration independently through a local urologist.

Telehealth visits for alprostadil in Texas typically cost between $75 and $199 out of pocket when insurance does not cover the consultation.

Labs and Evaluation Before Starting Alprostadil

Before prescribing alprostadil, clinicians in Texas and elsewhere follow a standard diagnostic workup. This is not a state-specific requirement but a clinical standard of care grounded in AUA and Endocrine Society guidelines [4].

The typical lab panel includes:

• Total and free testosterone. Low testosterone is a treatable cause of erectile dysfunction and should be identified before defaulting to local therapy.
• Hemoglobin A1c or fasting glucose. The Massachusetts Male Aging Study found that men with diabetes had a 3-fold higher age-adjusted probability of complete erectile dysfunction compared to non-diabetic men [5].
• Lipid panel. Dyslipidemia contributes to endothelial dysfunction, which underlies vasculogenic ED.
• PSA (if age-appropriate). While not directly related to alprostadil prescribing, a prostate cancer screening discussion is standard during urologic evaluation in men over 50, per USPSTF recommendations [6].
• CBC and comprehensive metabolic panel. Baseline organ function assessment.

A cardiovascular risk assessment is also recommended. The Princeton III Consensus guidelines classify ED patients into low, intermediate, and high cardiovascular risk categories and recommend evaluating cardiac status before initiating any ED therapy [7]. This applies to alprostadil just as it does to sildenafil.

Most labs can be drawn at any Quest Diagnostics or Labcorp location in Texas. Results are typically available within 48-72 hours.

Pharmacy Access and 503A Compounding in Texas

Texas has a strong compounding pharmacy sector. The Texas State Board of Pharmacy licenses 503A compounding pharmacies under Chapter 562 of the Texas Pharmacy Act. These pharmacies can prepare alprostadil in custom formulations, including combination injectables often called "trimix" (alprostadil + papaverine + phentolamine) or "bimix" (papaverine + phentolamine, without alprostadil).

503A pharmacies in Texas are permitted to ship compounded alprostadil within the state. Interstate shipping is more restricted. Under federal law (DQSA, 2013), 503A pharmacies generally must dispense compounded medications based on individual patient prescriptions and cannot distribute across state lines the way 503B outsourcing facilities can [8]. Patients in rural Texas (West Texas, the Panhandle, the Rio Grande Valley) can receive compounded alprostadil by mail from a Texas-licensed 503A pharmacy without traveling to a metro area.

For brand-name Caverject or MUSE, major retail chains (CVS, Walgreens, H-E-B Pharmacy) stock or can order the medication. Availability can vary. Caverject Impulse (the prefilled injection device) had intermittent supply constraints nationally in 2024-2025 [9]. Patients should call ahead to confirm stock.

Pricing without insurance ranges widely:

• Caverject Impulse (20 mcg, 2-pack): approximately $250-$500 at retail pharmacies.
• MUSE (six-suppository pack): approximately $400-$700 depending on dose strength.
• Compounded alprostadil injection (from 503A pharmacy): approximately $50-$150 per multi-dose vial, making compounding the most cost-effective route for many patients.

Manufacturer coupons from Pfizer and patient assistance programs may reduce costs for brand-name products. GoodRx and similar discount platforms often show significant price variation across Texas pharmacies.

Insurance and Prior Authorization in Texas

Most commercial insurance plans in Texas cover alprostadil when the patient meets step therapy requirements. The typical prior authorization process requires documentation that the patient:

1. Has a confirmed diagnosis of erectile dysfunction (ICD-10 code N52.01, N52.02, N52.03, or N52.9).
2. Has tried and failed, or has a documented contraindication to, at least one oral PDE5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil).
3. Has relevant lab work on file (testosterone level, metabolic panel).
4. Does not have a contraindication to alprostadil (such as conditions predisposing to priapism, including sickle cell disease or multiple myeloma).

Texas Medicaid does not cover alprostadil for erectile dysfunction. Coverage is limited to specific clinical scenarios unrelated to ED.

For patients with Blue Cross Blue Shield of Texas, United Healthcare, Aetna, or Cigna plans, prior authorization response times typically range from 48 hours to 14 days. The prescriber's office submits the PA request; the pharmacy cannot process the claim until approval is granted. Patients should plan for this delay.

Medicare Part D plans may cover alprostadil, but coverage varies by formulary. Many Part D plans place Caverject on Tier 3 (preferred brand) or Tier 4 (non-preferred brand), resulting in copays of $40-$100 per fill.

How Long Until You Receive Alprostadil in Texas

Timelines depend on the prescribing pathway:

In-person urology visit: If a patient sees a urologist who stocks alprostadil for in-office titration, the first dose can happen the same day. Take-home prescriptions filled at a retail pharmacy typically require 1-3 business days. Prior authorization adds 2-14 days.

Telehealth pathway: From initial intake to video visit is often 1-5 days. Prescription routing to a pharmacy takes hours. Retail fill time is 1-3 days. If using a 503A compounding pharmacy with shipping, allow 3-7 business days for preparation and cold-chain delivery.

Total realistic timeline (telehealth + compounding): 7-14 days from first contact to medication in hand.

Patients in Dallas-Fort Worth, Houston, San Antonio, and Austin generally have faster access because of pharmacy density. Patients in rural areas may add 2-4 days for shipping.

Dose Titration and Self-Injection Training

Alprostadil dose titration is a clinical process. It is not a "start at the standard dose and adjust" situation. The Caverject label specifies starting at 2.5 mcg for neurogenic ED (spinal cord injury, post-prostatectomy) and 2.5-10 mcg for vasculogenic ED, with stepwise increases of 5-10 mcg per visit until an erection adequate for intercourse is achieved [3].

The maximum recommended dose is 60 mcg for Caverject and 1 to 000 mcg for MUSE. Patients should not inject more than once in 24 hours and no more than three times per week.

In-office training typically takes 30-60 minutes and covers injection technique, anatomical landmarks, sterile procedure, and emergency protocols for priapism (defined as an erection lasting longer than 4 hours). The prescribing information warns that priapism occurred in 4% of patients in clinical trials, with pharmacologic intervention required in approximately 1% [3].

A 2015 systematic review and meta-analysis by Coombs et al. found that intracavernosal injection therapy had a satisfaction rate of 87% among ED patients, with discontinuation rates of approximately 40-50% at 2 years, primarily due to injection anxiety rather than lack of efficacy [10].

Transferring a Prescription to Texas

Patients relocating to Texas from another state can transfer an existing alprostadil prescription. Texas follows standard interstate prescription transfer rules: the receiving Texas pharmacy contacts the originating out-of-state pharmacy and processes the transfer electronically or by phone. Controlled substance transfer restrictions do not apply here because alprostadil is not a scheduled substance under the DEA or Texas Controlled Substances Act.

For compounded alprostadil, the process is slightly different. A compounding prescription is patient-specific and pharmacy-specific. If a patient moves from, say, Florida to Texas, the prescriber would need to write a new prescription directed to a Texas-licensed 503A pharmacy rather than transferring the original. This is a regulatory distinction, not a medical one. The prescriber can often reissue the prescription after a brief chart review or telehealth follow-up.

Patients should bring recent lab results and a copy of their medical records showing the current dose to expedite the transition.

Texas-Specific Regulatory Considerations

The Texas Medical Board has not imposed restrictions on alprostadil prescribing beyond federal requirements. There is no state-level step therapy mandate (although insurers may impose their own). There is no state monitoring program for alprostadil, unlike opioid PDMP requirements.

Texas does regulate telehealth prescribing through the Texas Medical Board's rules on telemedicine (22 TAC Chapter 174). A valid prescriber-patient relationship must be established before prescribing, and the prescriber must be licensed in Texas or hold an appropriate multi-state compact license. The prescriber must maintain adequate medical records and provide continuity of care or appropriate referral.

The Texas State Board of Pharmacy conducts inspections of 503A compounding pharmacies and enforces USP Chapter 797 standards for sterile compounding (alprostadil injection is a sterile preparation). Patients can verify a pharmacy's license status on the Board's website.